CD22 MicroBeads, human

CD22 MicroBeads, human

CD22 MicroBeads were developed for positive selection or depletion of human B cells from PBMCs, bone marrow, or single-cell suspensions from lymphoid tissues.

Background information

In peripheral blood, cell surface expression of the CD22 antigen is found on mature B cells, but is lost during terminal differentiation to plasma cells. In bone marrow, surface expression of CD22 can be detected from the pre-B cell stage on. Cytoplasmic expression of CD22 can also be found in late pro-B cells and early pre-B cells.

Downstream applications

The purified B cells may be used for cell biological studies, such as analysis of signal transduction
, mixed lymphocyte responses
, antigen presentation, or for molecular studies, e.g. PCR analysis


For positive selection: MS, LS, XS, or autoMACS
Columns. For depletion: LD, D, or autoMACS Columns.
  • Selected references

    1. Butch, A. W. et al. (1999) Human follicular dendritic cells inhibit superantigen-induced T-cell proliferation by distinct mechanisms. Blood 94: 216-224
    2. Jacquot, S. et al. (2001) B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int. Immunol. 13: 871-876
    3. Borson, N. D. et al. (2002) Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood 100: 4629-4639
Product options: 1

CD22 MicroBeads, human

for 1×
total cells
DKK 3.970,00